Metraipolis › archive › dc_2ebc285c9964
Exploring the top 30 drugs associated with drug-induced thrombotic microangiopathy based on the FDA adverse event reporting system — Europe PMC PMID:41050399
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41050399
- DOI
- 10.3389/fphar.2025.1658963
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T20:31:54.620Z
- SHA-256 of the archived text
9839ecdc576917e10f9d561ce16dacfa0fdd05d2fe4c05fa98f2ed46740d3d7a- Stable URL of this page
https://metraipolis.com/documento/dc_2ebc285c9964
How to cite
Exploring the top 30 drugs associated with drug-induced thrombotic microangiopathy based on the FDA adverse event reporting system — Europe PMC PMID:41050399 — Europe PMC (en), https://europepmc.org/article/MED/41050399 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ebc285c9964 (Metraipolis archive dc_2ebc285c9964, sha256 9839ecdc576917e10f9d561ce16dacfa0fdd05d2fe4c05fa98f2ed46740d3d7a)
BibTeX
@misc{dc2ebc285c9964,
title = {Exploring the top 30 drugs associated with drug-induced thrombotic microangiopathy based on the FDA adverse event reporting system — Europe PMC PMID:41050399},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41050399},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ebc285c9964; sha256 9839ecdc576917e10f9d561ce16dacfa0fdd05d2fe4c05fa98f2ed46740d3d7a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41050399. Agents can read the archived copy with the MCP tool read_document.